消化和肠道药物市场机会、成长动力、产业趋势分析和预测 2024 - 2032

Digestive and Intestinal Remedies Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: 2024年09月02日 | 出版商:

Global Market Insights Inc. | 英文 123 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023 年，全球消化和肠道药物市场价值为 195 亿美元，预计 2024 年至 2032 年复合年增长率为 3.5%。例如，加拿大消化健康基金会报告称，近 17% 的加拿大成年人患有胃食道逆流。症状包括胸痛、慢性咳嗽、胃灼热、睡眠呼吸中止症、逆流和打嗝。大量摄入加工食品和超重会导致这种情况，从而导致对消化和肠道药物的更高需求。

胃食道逆流症、肠躁症(IBS)、消化性溃疡、便秘、腹泻、发炎性肠道疾病(IBD) 和胃肠炎等疾病通常需要消化酵素、止泻药物和纤维补充剂等治疗方法。这些疗法对于治疗这些疾病至关重要。这些疗法的非处方药供应提高了它们的采用率。消化药物细分市场占据主导地位，到 2023 年将产生 103 亿美元的收入。

这些配方可有效缓解胃灼热、消化不良、腹胀、便秘和腹泻等症状。许多消化药物，如抗酸剂和质子帮浦抑制剂 (PPI)，都可以在柜檯购买，无需处方即可立即缓解。广泛的研究和悠久的使用历史巩固了这些药物在短期和长期应用中安全性的声誉。消化和肠道药物的市场份额分为线下和线上分销管道。

市场范围
开始年份	2023年
预测年份	2024-2032
起始值	195 亿美元
预测值	267 亿美元
复合年增长率	3.5%

预计到 2032 年，线上市场将达到 60 亿美元。这些平台 24/7 运行，确保随时可以获得补救措施，这对于那些在正常时间之外出现症状的人来说是有益的。

网路已成为健康资讯的主要来源，引导消费者在线上研究消化健康问题和补救措施。这种意识的提高影响了他们在数位平台上的购买决策。

2023 年，美国在消化和肠道药物市场中占了 74 亿美元的份额。美国领先公司专注于开发先进配方，特别是在质子帮浦抑制剂（PPI）和益生菌等领域，强调更持久的效果、减少副作用和增强功效。这一重点预计将提振美国市场。美国准备好保持其在市场的主导地位，推动成长和创新。

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
- 欧洲其他地区
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 阿联酋
- 中东和非洲其他地区

第 9 章：公司简介

Abbott Laboratories
Bayer AG
CH Boehringer Sohn AG & Co. KG.
China Resources Pharmaceutical Group Limited
Eli Lilly and Company
GlaxoSmithKline plc
Johnson & Johnson
Menarini Group
Merck & Co, Inc.
Pfizer Inc.
The Procter & Gamble Company
Reckitt Benckiser Group plc (RB)
Sanofi SA
Taisho Pharmaceutical Holdings Co., Ltd.
Takeda Pharmaceutical Company Limited

简介目录

Product Code: 11167

The Global Digestive And Intestinal Remedies Market was valued at USD 19.5 billion in 2023 and is projected to grow at a CAGR of 3.5% from 2024 to 2032. The increasing prevalence of gastrointestinal diseases drives this market. For instance, the Canadian Digestive Health Foundation reports that nearly 17% of Canadian adults suffer from GERD. Symptoms include chest pain, chronic cough, heartburn, sleep apnea, regurgitation, and belching. High intake of processed foods and being overweight contribute to this condition, leading to a higher demand for digestive and intestinal remedies.

Conditions such as GERD, irritable bowel syndrome (IBS), peptic ulcers, constipation, diarrhea, inflammatory bowel disease (IBD), and gastroenteritis often require remedies like digestive enzymes, anti-diarrheal medications, and fiber supplements. These remedies are essential for managing these ailments. The over-the-counter availability of these remedies boosts their adoption rate. The digestive medicines segment dominated the market, generating USD 10.3 billion in revenue in 2023. Digestive medicines, including both pharmaceutical and over-the-counter drugs, are formulated to alleviate a range of digestive issues.

These formulations effectively relieve symptoms such as heartburn, indigestion, bloating, constipation, and diarrhea. Many digestive medicines, like antacids and proton pump inhibitors (PPIs), are available over the counter, allowing individuals to access them for immediate relief without a prescription. Extensive research and a long history of use have cemented the reputation of these medicines for safety in both short-term and long-term applications. The market share of digestive and intestinal remedies is segmented into offline and online distribution channels.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$19.5 Billion
Forecast Value	$26.7 Billion
CAGR	3.5%

The online segment is anticipated to reach USD 6 billion by 2032. Online platforms enable consumers to purchase digestive and intestinal remedies from home, eliminating the need for a pharmacy visit. These platforms operate 24/7, ensuring remedies are accessible anytime, which is beneficial for those experiencing symptoms outside regular hours.

The internet has become a primary source of health information, leading consumers to research digestive health issues and remedies online. This increased awareness influences their purchasing decisions on digital platforms.The rise in telemedicine and online consultations allows healthcare providers to prescribe digestive remedies, which patients can promptly purchase online, further fueling market growth.

In 2023, the U.S. accounted for a significant USD 7.4 billion share of the digestive and intestinal remedies market. Leading companies in the U.S. focus on developing advanced formulations, particularly in areas like proton pump inhibitors (PPIs) and probiotics, emphasizing longer-lasting effects, reduced side effects, and enhanced efficacy. This focus is expected to bolster the U.S. market.Social media, health blogs, and online forums play a crucial role in educating consumers about digestive health, fostering informed purchasing decisions. The U.S. is poised to maintain its dominance in the market, driving both growth and innovation.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rise in incidence of gastrointestinal disorders
  - 3.2.1.2 Growing demand for related over-the-counter products
  - 3.2.1.3 Changes in natural food habits
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Availability of alternative therapies for gastrointestinal diseases
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Digestive medicines
5.3 Remedies against gastrointestinal complaints
5.4 Natural and synthetic agents

Chapter 6 Market Estimates and Forecast, By Age Group, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Adult
6.3 Pediatric

Chapter 7 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Offline
7.3 Online

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa